A new study by Monash University medicine safety experts found the use of gabapentinoids—medicines widely used to treat ...

A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to treat neuropathic pain -- increased the risk of hip fractures, especially in older patients who were ...

Neuropathic pain refers to pain caused by damage or disease to the nervous system.Neuropathic pain differs in pattern from ...

The resulting paper, “ Clinical study of a micro-implantable pulse generator for the treatment of peripheral neuropathic pain ...

Sangamo Therapeutics announced that the FDA has cleared the investigational new drug application for its ST-503 program, an investigational epigenetic regul ...

Researchers have found pregabalin highly effective in reducing neuropathic pain and itch in recessive dystrophic epidermolysis bullosa (RDEB), the most prevalent and debilitating form ...

At present, the impact of the pharmacogenetics on the response to treatment in neuropathic pain is poorly known, but several polymorphisms, among them the cytochrome P450 (CYP)2D6, may intervene.

Shares of Sangamo Therapeutics (NASDAQ:SGMO) rose 12% in post-market trading Tuesday after the company announced the FDA had ...

A new study from Monash University in Australia has found that gabapentinoids—commonly used drugs for treating neuropathic ...

A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil has concluded that the use of monochromatic ...

MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a preclinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...